Programmed cell death is considered an important pathway involved in the progressive decline of CD4+ T lymphocytes and in the anemia, granulocytopenia and thrombocytopenia, due to impaired CD34+ hematopoietic progenitor survival, occurring in several patients during HIV-related disease development [1,2,62]. The gene discussed is CD34; the disease is anemia.